脊椎変形性関節症鎮痛剤の世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D09983)
◆英語タイトル:Global Spine Osteoarthritis Pain Medicine Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D09983
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年11月7日(※2024年版があります。お問い合わせください。)
◆ページ数:127
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、脊椎変形性関節症鎮痛剤の世界市場について調査・分析し、種類別には、経口、注射、外用に、用途別には、医療、パーソナルケアに区分してまとめました。調査対象企業は、Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma等です。

・レポートの概要
・グローバル成長トレンド
・脊椎変形性関節症鎮痛剤の世界市場規模
・脊椎変形性関節症鎮痛剤の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別脊椎変形性関節症鎮痛剤の価格動向
・脊椎変形性関節症鎮痛剤の種類別市場規模(経口、注射、外用)
・脊椎変形性関節症鎮痛剤の用途別市場規模(医療、パーソナルケア)
・脊椎変形性関節症鎮痛剤の北米市場(アメリカ、カナダ、メキシコ)
・脊椎変形性関節症鎮痛剤のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・脊椎変形性関節症鎮痛剤のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・脊椎変形性関節症鎮痛剤の中南米市場(ブラジル等)
・脊椎変形性関節症鎮痛剤の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・脊椎変形性関節症鎮痛剤の市場規模予測
・脊椎変形性関節症鎮痛剤の種類別市場予測2018-2025(経口、注射、外用)
・脊椎変形性関節症鎮痛剤の用途別市場予測2018-2025(医療、パーソナルケア)
・脊椎変形性関節症鎮痛剤の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・脊椎変形性関節症鎮痛剤のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・脊椎変形性関節症鎮痛剤のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・脊椎変形性関節症鎮痛剤の中南米市場予測2018-2025(ブラジル等)
・脊椎変形性関節症鎮痛剤の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Spine Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.In 2018, the global Spine Osteoarthritis Pain Medicine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of 5.8% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Spine Osteoarthritis Pain Medicine.

This study researches the market size of Spine Osteoarthritis Pain Medicine, presents the global Spine Osteoarthritis Pain Medicine sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Spine Osteoarthritis Pain Medicine in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Spine Osteoarthritis Pain Medicine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Market Segment by Product Type
Oral
Injection
External

Market Segment by Application
Medical Care
Personal Care

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Spine Osteoarthritis Pain Medicine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Spine Osteoarthritis Pain Medicine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Spine Osteoarthritis Pain Medicine are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Spine Osteoarthritis Pain Medicine Market Size Growth Rate by Type
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Market Segment by Application
1.4.1 Global Spine Osteoarthritis Pain Medicine Market Share by Application (2018-2025)
1.4.2 Medical Care
1.4.3 Personal Care
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Spine Osteoarthritis Pain Medicine Market Size
2.1.1 Global Spine Osteoarthritis Pain Medicine Revenue 2013-2025
2.1.2 Global Spine Osteoarthritis Pain Medicine Sales 2013-2025
2.2 Spine Osteoarthritis Pain Medicine Growth Rate by Regions
2.2.1 Global Spine Osteoarthritis Pain Medicine Sales by Regions 2013-2018
2.2.2 Global Spine Osteoarthritis Pain Medicine Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Spine Osteoarthritis Pain Medicine Sales by Manufacturers
3.1.1 Spine Osteoarthritis Pain Medicine Sales by Manufacturers 2013-2018
3.1.2 Spine Osteoarthritis Pain Medicine Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Spine Osteoarthritis Pain Medicine Revenue by Manufacturers (2013-2018)
3.2.2 Spine Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Spine Osteoarthritis Pain Medicine Market Concentration Ratio (CR5 and HHI)
3.3 Spine Osteoarthritis Pain Medicine Price by Manufacturers
3.4 Key Manufacturers Spine Osteoarthritis Pain Medicine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Spine Osteoarthritis Pain Medicine Market
3.6 Key Manufacturers Spine Osteoarthritis Pain Medicine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Sales and Revenue (2013-2018)
4.1.2 Injection Sales and Revenue (2013-2018)
4.1.3 External Sales and Revenue (2013-2018)
4.2 Global Spine Osteoarthritis Pain Medicine Sales Market Share by Type
4.3 Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Type
4.4 Spine Osteoarthritis Pain Medicine Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Spine Osteoarthritis Pain Medicine Sales by Application

6 North America
6.1 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Company
6.2 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Type
6.3 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Application
6.4 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
6.4.1 North America Spine Osteoarthritis Pain Medicine Sales by Countries
6.4.2 North America Spine Osteoarthritis Pain Medicine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Company
7.2 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Type
7.3 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Application
7.4 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
7.4.1 Europe Spine Osteoarthritis Pain Medicine Sales by Countries
7.4.2 Europe Spine Osteoarthritis Pain Medicine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Company
8.2 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Type
8.3 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Application
8.4 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
8.4.1 Asia Pacific Spine Osteoarthritis Pain Medicine Sales by Countries
8.4.2 Asia Pacific Spine Osteoarthritis Pain Medicine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Company
9.2 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Type
9.3 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Application
9.4 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
9.4.1 Central & South America Spine Osteoarthritis Pain Medicine Sales by Countries
9.4.2 Central & South America Spine Osteoarthritis Pain Medicine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Breakdown Data by Type
10.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Breakdown Data by Application
10.3 Middle East and Africa Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
10.3.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Countries
10.3.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.1.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.2.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.3.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.4.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.5.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.6.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.7.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.8.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.9.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.10.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.12 TEVA
11.13 Almatica Pharma
11.14 Astellas Pharma
11.15 Tide Pharmaceutical
11.16 Iroko Pharmaceuticals
11.17 Hengrui Pharmaceutical
11.18 Abiogen Pharma

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Spine Osteoarthritis Pain Medicine Sales Channels
12.2.2 Spine Osteoarthritis Pain Medicine Distributors
12.3 Spine Osteoarthritis Pain Medicine Customers

13 Market Forecast
13.1 Global Spine Osteoarthritis Pain Medicine Sales and Revenue Forecast 2018-2025
13.2 Global Spine Osteoarthritis Pain Medicine Sales Forecast by Type
13.3 Global Spine Osteoarthritis Pain Medicine Sales Forecast by Application
13.4 Spine Osteoarthritis Pain Medicine Forecast by Regions
13.4.1 Global Spine Osteoarthritis Pain Medicine Sales Forecast by Regions 2018-2025
13.4.2 Global Spine Osteoarthritis Pain Medicine Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Spine Osteoarthritis Pain Medicine Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Spine Osteoarthritis Pain Medicine Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Spine Osteoarthritis Pain Medicine Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Spine Osteoarthritis Pain Medicine Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脊椎変形性関節症鎮痛剤の世界市場動向・分析2018-2025(Global Spine Osteoarthritis Pain Medicine Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。